=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-03-01
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Xylem Inc. (XYL)
CIK: 0001524472
--- Reporting Owner ---
Name: Grogan William K
CIK: 0001694002
Role: Officer (EVP & Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-03-01 | Code: A (Grant or award)
Shares: +5,551 | Price: $128.98
Total Value: $715,967.98
Shares Owned After: 33,801 | Ownership: D (Direct)
Footnotes:
[F1] Reflects the acquisition of 5,551 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
[F2] Includes additional shares due to dividend reinvestment.
[Transaction #2]
Security: Common Stock
Date: 2026-03-01 | Code: A (Grant or award)
Shares: +4,583 | Price: $128.98
Total Value: $591,115.34
Shares Owned After: 38,384 | Ownership: D (Direct)
Footnotes:
[F3] Reflects the acquisition of 4,583 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
[Transaction #3]
Security: Common Stock
Date: 2026-03-01 | Code: A (Grant or award)
Shares: +3,117 | Price: $128.98
Total Value: $402,030.66
Shares Owned After: 41,501 | Ownership: D (Direct)
Footnotes:
[F4] Reflects the acquisition of 3,117 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
[Transaction #4]
Security: Common Stock
Date: 2026-03-02 | Code: A (Grant or award)
Shares: +5,116 | Price: $0.00
Shares Owned After: 46,617 | Ownership: D (Direct)
Footnotes:
[F5] Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
[Transaction #5]
Security: Common Stock
Date: 2026-03-02 | Code: F (Payment of exercise/tax)
Shares: -5,888 | Price: $128.98
Total Value: $759,434.24
Shares Owned After: 40,729 | Ownership: D (Direct)
Footnotes:
[F6] Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
[Transaction #6]
Security: Common Stock
Date: 2026-03-02 | Code: F (Payment of exercise/tax)
Shares: -578 | Price: $128.98
Total Value: $74,550.44
Shares Owned After: 40,151 | Ownership: D (Direct)
Footnotes:
[F7] Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 (578) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
--- Derivative Transactions ---
[Transaction #1]
Security: Non-Qualified Stock Option (Right to Buy)
Date: 2026-03-02 | Code: A (Grant or award)
Shares: +18,228 | Price: $128.98
Exercisable: N/A | Expires: 2036-03-02
Shares Owned After: 18,228 | Ownership: D (Direct)
Footnotes:
[F8] Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
--- Footnotes (Complete Index) ---
F1: Reflects the acquisition of 5,551 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
F2: Includes additional shares due to dividend reinvestment.
F3: Reflects the acquisition of 4,583 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
F4: Reflects the acquisition of 3,117 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
F5: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
F6: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
F7: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 (578) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
F8: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
--- Signature ---
/s/ /s/ Mike Nazario, by power of attorney for William K. Grogan (2026-03-03)
